We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Viveve Medical Inc (VIVE) USD0.0001

Sell:$0.75 Buy:$0.83 Change: $0.0101 (1.29%)
Market closed |  Prices as at close on 16 May 2022 | Switch to live prices |
Sell:$0.75
Buy:$0.83
Change: $0.0101 (1.29%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 16 May 2022 | Switch to live prices |
Sell:$0.75
Buy:$0.83
Change: $0.0101 (1.29%)
Market closed |  Prices as at close on 16 May 2022 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Viveve Medical, Inc. designs, develops, manufactures, and markets a platform medical technology, Cryogen-cooled Monopolar Radiofrequency (CMRF). The Company's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The Company's subsidiary includes Viveve, Inc. and Viveve BV.

Contact details

Address:
345 Inverness Dr S Bldg B Ste 250
ENGLEWOOD
80112-5889
United States
Telephone:
+1 (408) 5301900
Website:
https://us.viveve.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
VIVE
ISIN:
US92852W5013
Market cap:
$8.28 million
Shares in issue:
10.62 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Scott Durbin
    Chief Executive Officer, Director
  • Jim Robbins
    Senior Vice President - Finance and Administration

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.